Camostat mesylate therapy in critically ill patients with COVID-19 pneumonia
Yasser Sakr, Hatim Bensasi, Ahmed Taha, Michael Bauer, Khaled M. Ismail, Ghazala Belhaj, Khaled M. Afet, Dnyanwshwar Munde, David Monk, Samuel Buschbeck
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Critically illPneumoniaAnesthesiologyIntensive care medicinePain medicine2019-20 coronavirus outbreakMesylateSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Critical illnessInternal medicineAnesthesiaVirologyDiseaseInfectious disease (medical specialty)OutbreakChemistryOrganic chemistryLong-Term Effects of COVID-19COVID-19 Clinical Research StudiesNanoplatforms for cancer theranostics